Daniel Paul Caley
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Extracellular vesicles in disease
- Genomics and Phylogenetic Studies
Papers in
-
- MicroRNA in disease regulation 3
- Cancer-related molecular mechanisms research 2
- Genetics 1
- Hemoglobinopathies and Related Disorders 1
- Co-authors
- David R. F. Carter (7 shared papers)Ryan Charles Pink (6 shared papers)Laura Ann Jacobs (1 shared paper)Kate Wicks (1 shared paper)Priya Samuel (2 shared papers)Susan Ann Brooks (2 shared papers)Daniel Trujillano (1 shared paper)Naresh Magan (1 shared paper)
- Journals
- PLoS ONE (3 papers)Clinical Cancer Research (1 paper)Gynecologic Oncology (1 paper)Tumor Biology (1 paper)Toxins (1 paper)
- Partner nations
- United KingdomCanadaSpain
In The Last Decade
Daniel Paul Caley
10 papers receiving 882 citations
Peers
Comparison fields: 5 of 74
- Cancer Research 333
- Molecular Biology 292
- Reproductive Medicine 44
- Aging 6
- Pulmonary and Respiratory Medicine 101
Countries citing papers authored by Daniel Paul Caley
This map shows the geographic impact of Daniel Paul Caley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Paul Caley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Paul Caley more than expected).
Fields of papers citing papers by Daniel Paul Caley
This network shows the impact of papers produced by Daniel Paul Caley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Paul Caley. The network helps show where Daniel Paul Caley may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Paul Caley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 354 | |
| 2 | 2015 | 174 | |
| 3 | 2010 | 121 | |
| 4 | 2015 | 67 | |
| 5 | 2011 | 54 | |
| 6 | 2016 | 53 | |
| 7 | 2015 | 48 | |
| 8 | 2013 | 26 | |
| 9 | 2010 | 4 | |
| 10 | 2019 | 3 |
About Daniel Paul Caley
Daniel Paul Caley is a scholar working on Cancer Research, Genetics, Pulmonary and Respiratory Medicine, Plant Science and Molecular Biology, having authored 10 papers that have together received 904 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (3 papers), Cancer-related molecular mechanisms research (2 papers), Prostate Cancer Treatment and Research (2 papers), Genomics and Chromatin Dynamics (2 papers), Mycotoxins in Agriculture and Food (1 paper), Hemoglobinopathies and Related Disorders (1 paper) and Chromosomal and Genetic Variations (1 paper). The work is most often cited by research in Cancer Research (333 citations), Molecular Biology (292 citations), Reproductive Medicine (44 citations), Aging (6 citations) and Pulmonary and Respiratory Medicine (101 citations). Daniel Paul Caley has collaborated with scholars based in United Kingdom, Canada and Spain. Frequent co-authors include David R. F. Carter, Ryan Charles Pink, Laura Ann Jacobs, Kate Wicks, Priya Samuel, Susan Ann Brooks, Daniel Trujillano, Naresh Magan, Ahmed Abdel-Hadi and Yusuke Imamura. Their work appears in journals such as PLoS ONE, Clinical Cancer Research, Gynecologic Oncology, Tumor Biology and Toxins.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.